Biocon surges 14% after US FDA gives approval to biosimilar version of Herceptin News News / News 6 years ago 484 Views comments Mylan and Biocon said that USFDA approved Mylanâs Ogivri, a biosimilar to Swiss biotech giant Roche#39;s blockbuster cancer drug Herceptin, co-devel... Read more
News Pixelbook, Home speakers and an AI Camera: 5 products Google has unveiled News / News - 6 years ago
Comments